A Region of Human CD14 Required for Lipopolysaccharide Binding

This publication has 22 references indexed in Scilit:

• Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
  The Journal of Experimental Medicine, 1994
• Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.
  Proceedings of the National Academy of Sciences, 1993
• Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
  Proceedings of the National Academy of Sciences, 1993
• Recognition of Bacterial Endotoxins by Receptor-Dependent Mechanisms
  Published by Elsevier ,1993
• Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
  The Journal of Experimental Medicine, 1992
• Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
  The Journal of Immunology, 1992
• Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
  The Journal of Experimental Medicine, 1992
• CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
  Science, 1990
• Cachectin: More Than a Tumor Necrosis Factor
  New England Journal of Medicine, 1987
• Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
  Science, 1986